Nibec Co Ltd is a Korea-based company primarily engaged in the manufacturing of oral medical products and supplies business. The Company is mainly engaged in the manufacturing of dental bone graft materials and biomaterials. In addition, the Company is engaged in the manufacture of dental antibiotic ointment and syringe-treatment products. The Company sells its products in domestic and overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-10-07	₩16,070.00	-3.02%	20,787
26-10-06	₩16,570.00	+3.69%	47,423
26-10-02	₩15,980.00	-2.02%	30,675
26-10-01	₩16,310.00	+3.89%	62,876
26-09-30	₩15,700.00	+2.41%	35,555

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-10-06			5-day change	1st Jan Change
16,570.00 ^KRW	+3.69%		+8.09%	-55.87%

22-11-21	NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	CI
22-11-17	NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	CI

Market Cap	183B 136M 122M 114M 103M 194M 13.19B 196M 1.37B 534M 6.71B 512M 501M 21.57B	P/E 2024	-17.8x	P/E 2025	90.9x
Enterprise Value	169B 126M 113M 105M 95.72M 180M 12.23B 182M 1.27B 495M 6.22B 475M 464M 19.99B	EV / Sales 2024	6.79x	EV / Sales 2025	12.6x
Free-Float	80.7%	Yield 2024 *	-	Yield 2025	-

22-11-21	NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	CI
22-11-17	NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	CI
21-09-20	NIBEC Co., Ltd.(KOSDAQ:A138610) added to S&P Global BMI Index	CI
20-12-27	NIBEC Co., Ltd. announced that it has received KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm	CI
20-12-22	NIBEC Co., Ltd. announced that it expects to receive KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm	CI
17-12-25	NIBEC Co., Ltd. announced that it has received KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd.	CI
17-12-21	NIBEC Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd.	CI
16-03-30	NIBEC Co. Ltd. announced that it has received KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors.	CI
16-03-29	NIBEC Co. Ltd. announced that it expects to receive KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors.	CI
15-03-01	NIBEC Co. Ltd. announced that it has received KRW 2 billion in funding.	CI
15-02-25	NIBEC Co. Ltd. announced that it expects to receive KRW 2 billion in funding.	CI

1 day	+3.69%
1 week	+8.09%
Current month	+5.54%
1 month	+9.30%
3 months	-0.72%
6 months	-33.98%
Current year	-55.87%

NIBEC Co., Ltd. Stock

Stocks

A138610

KR7138610001

Biotechnology & Medical Research

Valuation: NIBEC Co., Ltd.

Chart: NIBEC Co., Ltd.

Latest news: NIBEC Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: NIBEC Co., Ltd.

Bio Medical Devices

Financials

Company Profile

Quotes

1 week	15,480	16,590
1 month	13,940	16,590
Current year	11,230	40,400
1 year	11,230	54,300
3 years	11,230	54,300
5 years	11,230	54,300
10 years	4,800	55,500

Manager	Title	Age	Since
Jong-Pyeong Jeong CEO	Chief Executive Officer	80	2003-12-31
Yoon-Jeong Park PRN	Corporate Officer/Principal	55	-
Yang-Jo Seol AUD	Comptroller/Controller/Auditor	58	2012-03-29

Director	Title	Age	Since
Jong-Pyeong Jeong BRD	Director/Board Member	80	2003-12-31
Yoon-Jeong Park BRD	Director/Board Member	55	-
Joo-Yeon Lee BRD	Director/Board Member	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NIBEC CO., LTD.	+3.69%	+8.09%	-53.65%	-17.36%	136M
WUXI APPTEC CO., LTD.	+4.16%	+4.16%	+49.37%	+94.17%	74.68B
ARGENX SE	-13.38%	-13.88%	+5.47%	+55.20%	58.7B
LONZA GROUP AG	-1.39%	+1.21%	+4.15%	+32.26%	48.36B
REVOLUTION MEDICINES, INC.	+0.50%	-2.14%	+331.33%	+702.20%	43.05B
IQVIA HOLDINGS INC.	-0.72%	-3.99%	+28.50%	+29.94%	42.48B
BEONE MEDICINES AG	+0.34%	-0.52%	+6.56%	+109.35%	41.39B
CELLTRION, INC.	-0.11%	+1.96%	+9.19%	+52.66%	31.29B
BIONTECH SE	-0.50%	-3.10%	-10.19%	-14.35%	23.93B
INSMED INCORPORATED	-3.32%	-10.86%	-37.32%	+316.28%	22.22B
Average	-1.09%	-1.15%	+33.34%	+136.04%	38.62B
Weighted average by Cap.	-1.65%	-1.56%	+49.62%	+145.49%

	2024	2025
Net sales	24.55B 18.33M 16.37M 15.28M 13.88M 26.13M 1.77B 26.33M 184M 71.72M 902M 68.8M 67.31M 2.9B	32.72B 24.42M 21.82M 20.36M 18.49M 34.83M 2.36B 35.09M 245M 95.58M 1.2B 91.69M 89.71M 3.86B
Net income	-9.33B -6.96M -6.22M -5.8M -5.27M -9.93M -673M -10M -69.74M -27.25M -343M -26.14M -25.57M -1.1B	4.64B 3.47M 3.1M 2.89M 2.62M 4.94M 335M 4.98M 34.71M 13.56M 170M 13.01M 12.73M 548M
Net Debt	-7.34B -5.48M -4.9M -4.57M -4.15M -7.82M -530M -7.88M -54.91M -21.45M -270M -20.58M -20.13M -867M	-13.34B -9.95M -8.89M -8.3M -7.54M -14.2M -963M -14.3M -99.72M -38.96M -490M -37.37M -36.56M -1.57B